Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 3;12(11):e064038.
doi: 10.1136/bmjopen-2022-064038.

Perceived feasibility, facilitators and barriers to incorporating point-of-care testing for SARS-CoV-2 into emergency medical services by ambulance service staff: a survey-based approach

Affiliations

Perceived feasibility, facilitators and barriers to incorporating point-of-care testing for SARS-CoV-2 into emergency medical services by ambulance service staff: a survey-based approach

Kile Green et al. BMJ Open. .

Abstract

Objectives: This body of work aimed to elicit ambulance service staff's perceptions on the barriers and facilitators to adoption, and clinical utility of incorporating rapid SARS-CoV-2 testing during ambulance assessments.

Design: A mixed-methods survey-based project using a framework analysis method to organise qualitative data.

Setting: Emergency and non-emergency care ambulatory services in the UK were approached to take part.

Participants: Current, practising members of the UK ambulance service (paramedics, technicians, assistants and other staff) were included in this body of work.

Results: Survey 1: 226 responses were collected between 3 December 2020 and 11 January 2021, 179 (79.2%) of which were completed in full. While the majority of respondents indicated that an ambulance-based testing strategy was feasible in concept (143/190, 75.3%), major barriers to adoption were noted. Many open-ended responses cited concerns regarding misuse of the service by the general public and other healthcare services, timing and conveyance issues, and increased workloads, alongside training and safety concerns. Survey 2: 26 responses were received between 8 February 2021 and 22 February 2021 to this follow-up survey. Survey 2 revealed conveyance decision-making, and risk stratification to be the most frequently prioritised use cases among ambulance service staff. Optimal test characteristics for clinical adoption according to respondents were; accuracy (above 90% sensitivity and specificity), rapidity (<30 min time to results) and ease of sample acquisition.

Conclusions: The majority of commercially available lateral flow devices are unlikely to be supported by paramedics as their duty of care requires both rapid and accurate results that can inform clinical decision making in an emergency situation. Further investigation is needed to define acceptable test characteristics and criteria required for ambulance service staff to be confident and supportive of deployment of a SARS-CoV-2 test in an emergency care setting.

Keywords: COVID-19; Molecular diagnostics; QUALITATIVE RESEARCH.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Summary of use cases for rapid SARS-COV-2 testing in ambulances. A total of 170 respondents stated their preferred use cases for a rapid SARS-CoV-2 test in the ambulance service as displayed in this stacked chart. The length of the bar represents the number of respondents providing that use case, with the colours representing the categories of ambulance service staff. A call-out text box displays the main quotes from respondents that noted ‘other’ as their preferred use case.
Figure 2
Figure 2
Summary scores for most important test characteristics for SARS-CoV-2 testing in an ambulance setting. Summary scores for the Likert ranking of test characteristics for a rapid SARS-CoV-2 test in the ambulance service are displayed in this chart. Likert scores ranged from −2 (Not important) to +2 (Most important). mean score and SD of the results are displayed in the figure.
Figure 3
Figure 3
Summary scores for perceived usefulness of hypothetical SARS-CoV-2 tests for top use cases identified though survey. Summary scores for the Likert ranking of use cases and accuracy statistics for a rapid SARS-CoV-2 test in the ambulance service are displayed in this chart. Likert scores ranged from −2 (Not important) to +2 (Most important). The length of the bars indicates the mean Likert score, while the colour represents the three hypothetical tests referred to in the figure key.

References

    1. Dinnes J, Deeks JJ, Adriano A, et al. . Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev 2020;8:CD013705. 10.1002/14651858.CD013705 - DOI - PMC - PubMed
    1. FindDX . FindDX SARS-CoV-2 diagnostic pipeline, 2021. Available: https://www.finddx.org/covid-19/pipeline/
    1. Bossuyt PM, Irwig L, Craig J, et al. . Comparative accuracy: assessing new tests against existing diagnostic pathways. BMJ 2006;332:1089–92. 10.1136/bmj.332.7549.1089 - DOI - PMC - PubMed
    1. Ferrante di Ruffano L, Hyde CJ, McCaffery KJ, et al. . Assessing the value of diagnostic tests: a framework for designing and evaluating trials. BMJ 2012;344:e686. 10.1136/bmj.e686 - DOI - PubMed
    1. García-Fiñana M, Hughes DM, Cheyne CP, et al. . Performance of the Innova SARS-CoV-2 antigen rapid lateral flow test in the Liverpool asymptomatic testing pilot: population based cohort study. BMJ 2021;374: :n1637. 10.1136/bmj.n1637 - DOI - PMC - PubMed

Publication types